在过去的20年里,对禽类死肠炎的实验模型和诱导协议进行了全面的审查
Mohammad Ali Shamshirgaran1, Mehdi Golchin1
1Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran.
Frontiers in veterinary science
|August 8, 2024
概括
死亡性肠炎 (NE) 是一种需要新的控制方法的家禽疾病. 本综述详细介绍了家禽死肠炎 (NE) 的有效实验性生殖技术,有助于研究替代治疗方法.
科学领域:
- 禽畜科学 禽畜科学 禽畜科学
- 兽医医学 兽医医学 兽医医学
- 动物病理学 动物病理学
背景情况:
- 结核性肠炎 (NE) 在家禽行业造成重大经济损失,原因是肠道损伤和死亡率.
- 消除抗菌剂需要使用替代策略来控制NE.
- 准确的NE实验复制对于评估预防措施至关重要.
研究的目的:
- 在实验性家禽研究中提供对生殖死肠炎 (NE) 的方法的全面概述.
- 分析成功的NE诱导和病变评分的关键参数.
- 引导研究人员选择适合NE研究的实验设计.
主要方法:
- 从2004年到2023年对实验性NE生殖方法的审查.
- 关键因素的分析:Clostridium perfringens菌株选择,注射剂的准备,挑战的管理 (时间和路径),以及易感因素.
- 评估不同的NE损伤评分系统.
主要成果:
- 在家禽模型中确定了用于一致和有效的NE诱导的关键参数.
- 强调了特定Clostridium perfringens菌株和易感因素的重要性.
- 总结了各种损伤评分技术,以评估NE严重程度.
结论:
- 对NE的标准化实验复制对于对抗策略的可靠研究至关重要.
- 了解这些方法参数可以提高对替代性NE治疗研究的有效性.
- 本综述为设计在家禽研究中强大的NE实验模型提供了一个框架.
相关概念视频
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...


